Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 228 clinical trials
featured
A Platform Study Exploring the Safety, Tolerability, Effect on the Tumor Microenvironment, and Efficacy of INCB Combinations in Advanced Solid Tumors

A Platform Study Exploring the Safety, Tolerability, Effect on the Tumor Microenvironment, and Efficacy of INCB Combinations in Advanced Solid Tumors

solid tumors
solid tumor
  • 264 views
  • 08 Dec, 2020
  • 11 locations
featured
A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors

The purpose of this open-label nonrandomized Phase 1/2 study is to evaluate INCB001158 in combination with chemotherapy in participants with advanced/metastatic solid tumors.  

metastatic cancer
solid tumors
measurable disease
cancer
solid tumor
  • 38 views
  • 14 Dec, 2020
  • 13 locations
featured
A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of INCMGA00012 (formerly MGA012) in Patients with Advanced Solid Tumors

INCMGA00012 administered IV every two or four weeks in patients with relapsed/refractory, unresectable locally advanced or metastatic solid tumors.  The study consists of two phases, a Dose

measurable disease
cancer
primary cancer
endometrial carcinoma
  • 229 views
  • 14 Dec, 2020
  • 16 locations
featured
A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

The purpose of this study is to evaluate the efficacy and safety of pemigatinib in participants with previously treated locally advanced/metastatic or surgically unresectable solid tumor malignancies harboring activating FGFR mutations or translocations.  

FGFR2
FGFR1
primary cancer
malignancy
administration intravenous
  • 46 views
  • 14 Dec, 2020
  • 62 locations
featured
Advanced or Metastatic Solid Tumors

People with solid tumors are asked to participate in a research study being conducted by Montefiore Medical Center.  

  • 25 views
  • 20 Feb, 2019
  • 1 location
featured
Advanced or Metastatic Solid Tumors

People with solid tumors are asked to participate in a research study being conducted by Northwell Health / Monter Cancer Center.  

  • 45 views
  • 27 Jun, 2019
  • 1 location
featured
Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors

  • 172 views
  • 08 Nov, 2020
  • 1 location
featured
Locally Advanced or Metastatic Solid Tumors

People with advanced or metastatic solid tumors are asked to participate in a research study being conducted by Montefiore Medical Center.  

  • 34 views
  • 22 Feb, 2019
  • 1 location
featured
An Open-Label, Dose-Escalation, Safety Tolerability Study of INCAGN01876 in Subjects With Advanced or Metastatic Solid Tumors

An Open-Label, Dose-Escalation, Safety Tolerability Study of INCAGN01876 in Subjects With Advanced or Metastatic Solid Tumors

solid tumors
advanced solid tumor
solid tumor
  • 80 views
  • 08 Dec, 2020
  • 7 locations
featured
A Phase 1/2 Study of HDAC Inhibitor, Mocetinostat, in Combination With PD-L1 Inhibitor, Durvalumab, in Advanced or Metastatic Solid Tumors and Non Small Cell Lung Cancer

A Phase 1/2 Study of HDAC Inhibitor, Mocetinostat, in Combination With PD-L1 Inhibitor, Durvalumab, in Advanced or Metastatic Solid Tumors and Non Small Cell Lung Cancer

  • 314 views
  • 23 Nov, 2020
  • 4 locations